Carcinoembryonic antigen (CEA)

Meta Analysis

Matrix: Serum/plasma

Type median CV estimate lower CI limit higher CI limit Date Updated Tools
Between-subject
45.3
37.1
58.3
2020-11-20 12:01:00 UTC

References

No meta analysis Reference included in meta calculation Reference not included in meta calculation
Link Estimate of CVi Estimate of CVg Gender State of Well Being Matrix
Assessment of biological variation and analytic impreciion of CA 125, CEA and TPA in relation to monitoring of ovarian cancer, Tuxen MK, Solétormos G, Pertersen PH, Cioler V, Dombernovsky P, 1999, Gynecologic Oncology, 74, 12-22 12.6 58.3 Females Healthy (excl pregnant) Serum
Biological variation and reference change vàlues of CA 19-9, CEA, AFP in sèrum of healthy individuals, Erden G, Barazi AO, Tezcan G and Yildirimkaya MM, 2008, Scand J Clin Lab Invest, 68, 212-8 30.87 37.14 Mixed Healthy (excl pregnant) Serum
Witin-subject biological variation in disease: the case of tumour markers, Dittadi R, Peloso L and Gion M, 2008, Ann Clin Biochem, 45, 226-8 8.4 Mixed Healthy (excl pregnant) Unknown
Witin-subject biological variation in disease: the case of tumour markers, Dittadi R, Peloso L and Gion M, 2008, Ann Clin Biochem, 45, 226-8 19.3 Mixed Healthy (excl pregnant) Unknown
Serum tumor markers in monitoring patients: interpretation of results using analytical and biological variation, Plebani M, Giacomini A, Beghi L, De Paoli M, Roveroni G, Galleotti F, Corsini A, Fraser CG, 1996, Anticancer Res, 16, 2249-52 10.9 178.0 Mixed Non-healthy (excl pregnant) Serum
Biological variation of tumor markers and its aplication in the detection of disease progression in patients with non-samll cell lung cancer, Trapé J, Perez de Olaguer J, Buxó J and López L, 2005, Clin Chem, 51, 219-22 9.9 35.6 Males Non-healthy (excl pregnant) Serum
. Biological variations of seven tumor markers, Qi Z, Zhang Lin, Chen Y, Ma X et al, 2015, Clin Chim Acta, 450, 233-6 10.95 46.74 Mixed Healthy (excl pregnant) Serum
Serum tumor markers in monitoring patients: interpretation of results using analytical and biological variation, Plebani M, Giacomini A, Beghi L, De Paoli M, Roveroni G, Galleotti F, Corsini A, Fraser CG, 1996, Anticancer Res, 16, 2249-52 10.9 178.0 Males Non-healthy (excl pregnant) Serum
Interpretation of sequential measurements of cancer Antigen 125 (CA 125), Carcinoembryonic Antigen (CEA) and Tissue Polypeptide Antigen (TPA) based on analytical imprecision and biological variation in the monitoring of ovarian cancer, Tuxen MK, Sölétormos G, Petersen PH and Dombernowsky P, 2001, Clin Chem Lab Med, 39, 531-8 17.3 Females Healthy (excl pregnant) Serum
Interpretation of results for tumor markers on the basis of analytical imprecision an biological variation, Sölétormos G, Schioler V, Nielsen D, Skovsgaard T, Domnerbowsky P, 1993, Clin Chem, 39, 2077-83 9.3 86.8 Females Healthy (excl pregnant) Serum
© 2018 - 2020 This website and its content is copyright of EFLM. All rights reserved. Any redistribution or reproduction of part or all of the contents in any form is prohibited other than the following: you may print or download to a local hard disk extracts for your personal and non-commercial use only you may copy the content to individual third parties for their personal use, but only if you acknowledge the website as the source of the material You may not, except with our express written permission, distribute or commercially exploit the content. Nor may you transmit it or store it in any other website or other form of electronic retrieval system.

Email Us

European Federation of Clinical Chemistry and Laboratory Medicine
Via Carlo Farini 81
20159 Milano - Italy